Accurate medication history and access to expensive therapeutics can lead to improved health outcomes and reduced utilization. Yet, hospitals have a high prevalence of medication errors, both during admission and discharge. Meanwhile, over a dozen pharmaceutical companies have reduced their 340B drug pricing programs, which when combined with ongoing controversy related to oversight, transparency, and eligibility, results in cash strapped patients and safety-net hospitals struggling to afford and deliver crucial drug therapies. Reconciliation and drug affordability are just the tip of the iceberg to be explored by this panel of industry trailblazers. Join this session to discover insights, improve navigation, and even plot the great escape from what has become the medication management maze.